CFM
MRVI icon

Capricorn Fund Managers’s Maravai LifeSciences MRVI Stock Holding History

Capricorn Fund Managers’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-339,727
Closed -$961K – 202
2026
Q1 		$961K Buy
+339,727
New +$1.15M 0.15% 91

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Capricorn Fund Managers's MRVI Position: Q2 2026 in Review

Capricorn Fund Managers sold out of Maravai LifeSciences (MRVI) in Q2 2026, closing a stake of 339,727 shares — an estimated $961K sold.

Capricorn Fund Managers first reported a position in MRVI in Q1 2026 and held it in 1 quarter. The position peaked at $961K in Q1 2026. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Capricorn Fund Managers reported no remaining Maravai LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Capricorn Fund Managers sold 339,727 Maravai LifeSciences shares in Q2 2026, an estimated $961K.
  • Capricorn Fund Managers first reported a position in Maravai LifeSciences in Q1 2026 and held it in 1 quarter.
  • Capricorn Fund Managers's Maravai LifeSciences position peaked at $961K in Q1 2026.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.